Search research articles
Contact Us
Filters
Showing results (1191-1200 of 1,213) with videos related to
Page
of 122
Sort By:
Genome Biology
|
August 29, 2014
Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions
A Rose Brannon, Efsevia Vakiani, Brooke E Sylvester, et al.
Journal of the National Cancer Institute
|
November 15, 2007
Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer
Alison M Hosey, Julia J Gorski, Margaret M Murray, et al.
European Urology
|
August 6, 2014
Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder
Philip H Kim, Eugene K Cha, John P Sfakianos, et al.
The Journal of Urology
|
January 19, 2016
Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma
Aditya Bagrodia, Eugene K Cha, John P Sfakianos, et al.
Genomics
|
March 10, 2000
A 6-Mb high-resolution physical and transcription map encompassing the hereditary prostate cancer 1 (HPC1) region
J D Carpten, I Makalowska, C M Robbins, et al.
Cancer
|
August 9, 2020
A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma
Victor McPherson, Brendan Reardon, Aravind Bhayankara, et al.
EMBO Reports
|
November 1, 2024
The 24-hour molecular landscape after exercise in humans reveals MYC is sufficient for muscle growth
Sebastian Edman, Ronald G Jones Iii, Paulo R Jannig, et al.
ACS Applied Materials & Interfaces
|
December 13, 2021
Functionalized Terpolymer-Brush-Based Biointerface with Improved Antifouling Properties for Ultra-Sensitive Direct Detection of Virus in Crude Clinical Samples
Michala Forinová, Alina Pilipenco, Ivana Víšová, et al.
Cancer Research
|
November 29, 2013
Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis
Joanne R Doherty, Chunying Yang, Kristen E N Scott, et al.
Cancer Discovery
|
June 18, 2014
Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy
Hikmat Al-Ahmadie, Gopa Iyer, Marcel Hohl, et al.
Page
of 122
Search research articles
Search
Showing results (1191-1200 of 1,213) with videos related to
Sort By:
Page
of 122
Genome Biology
|
August 29, 2014
Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions
A Rose Brannon, Efsevia Vakiani, Brooke E Sylvester, et al.
Journal of the National Cancer Institute
|
November 15, 2007
Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer
Alison M Hosey, Julia J Gorski, Margaret M Murray, et al.
European Urology
|
August 6, 2014
Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder
Philip H Kim, Eugene K Cha, John P Sfakianos, et al.
The Journal of Urology
|
January 19, 2016
Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma
Aditya Bagrodia, Eugene K Cha, John P Sfakianos, et al.
Genomics
|
March 10, 2000
A 6-Mb high-resolution physical and transcription map encompassing the hereditary prostate cancer 1 (HPC1) region
J D Carpten, I Makalowska, C M Robbins, et al.
Cancer
|
August 9, 2020
A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma
Victor McPherson, Brendan Reardon, Aravind Bhayankara, et al.
EMBO Reports
|
November 1, 2024
The 24-hour molecular landscape after exercise in humans reveals MYC is sufficient for muscle growth
Sebastian Edman, Ronald G Jones Iii, Paulo R Jannig, et al.
ACS Applied Materials & Interfaces
|
December 13, 2021
Functionalized Terpolymer-Brush-Based Biointerface with Improved Antifouling Properties for Ultra-Sensitive Direct Detection of Virus in Crude Clinical Samples
Michala Forinová, Alina Pilipenco, Ivana Víšová, et al.
Cancer Research
|
November 29, 2013
Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis
Joanne R Doherty, Chunying Yang, Kristen E N Scott, et al.
Cancer Discovery
|
June 18, 2014
Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy
Hikmat Al-Ahmadie, Gopa Iyer, Marcel Hohl, et al.
Page
of 122